Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gene expression profiling of multiple myeloma].

Stéphane Minvielle1

  • 1Inserm U463, Institut de Biologie, 9, quai Moncousu, 44035 Nantes Cedex. sminviel@nantes.inserm.fr

Bulletin Du Cancer
|March 28, 2003
PubMed
Summary

Multiple myeloma exhibits significant patient heterogeneity. Gene expression profiling of plasma cells may offer a future molecular prognostic indicator for improved patient classification and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial.

Blood cancer journal·2026
Same author

Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

Blood cancer journal·2026
Same author

Role and timing of chromosome deletions in multiple myeloma.

Blood·2024
Same author

Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implications.

Blood advances·2024
Same author

A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics.

Blood·2023
Same author

Author Correction: Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.

Nature cancer·2023

Area of Science:

  • Hematology
  • Oncology
  • Genomics

Background:

  • Multiple myeloma is characterized by malignant plasma cell accumulation.
  • Significant heterogeneity exists among patients regarding clinical presentation, treatment response, and survival.
  • Current prognostic markers inadequately predict individual patient outcomes.

Purpose of the Study:

  • To investigate gene expression profiles in multiple myeloma.
  • To identify genes involved in plasma cell transformation.
  • To explore the potential of gene expression-based classification for prognosis.

Main Methods:

  • Analysis of DNA microarrays from myeloma plasma cells.
  • Comparison of gene expression profiles between myeloma and normal/immortalized plasma cells.
  • Identification of genes associated with the transformation process.

Main Results:

  • Gene expression profiling provides an overview of plasma cell gene programs.
  • Potential transformation-related genes were identified through comparative analysis.
  • Observed heterogeneity in myeloma suggests a need for refined prognostic tools.

Conclusions:

  • Gene expression analysis offers insights into multiple myeloma biology.
  • Future gene expression-based classifications may serve as molecular prognostic indicators.
  • This approach could lead to more personalized treatment strategies for multiple myeloma patients.

Related Experiment Videos